Effect of diethyldithiocarbamate on toxicity of doxorubicin, cyclophosphamide and cis-diamminedichloroplatinum (II) on mice haemopoietic progenitor cells.

Por Pannacciulli, I. M., Lerza, R. A., Bogliolo, G. V., Mencoboni, M. P., Saviane, A. G.
Publicado em 1989

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials

Por Ceresoli, G L, Castagneto, B, Zucali, P A, Favaretto, A, Mencoboni, M, Grossi, F, Cortinovis, D, Conte, G Del, Ceribelli, A, Bearz, A, Salamina, S, De Vincenzo, F, Cappuzzo, F, Marangolo, M, Torri, V, Santoro, A
Publicado em 2008

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey

Por Ceresoli, G L, Grosso, F, Zucali, P A, Mencoboni, M, Pasello, G, Ripa, C, Degiovanni, D, Simonelli, M, Bruzzone, A, Dipietrantonj, C, Piccolini, E, Beretta, G D, Favaretto, A G, Giordano, L, Santoro, A, Botta, M
Publicado em 2014

Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB–IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial tr...

Por Boni, C, Tiseo, M, Boni, L, Baldini, E, Recchia, F, Barone, C, Grossi, F, Germano, D, Matano, E, Marini, G, Labianca, R, Di Costanzo, F, Bagnulo, A, Pennucci, C, Caroti, C, Mencoboni, M, Zanelli, F, Prochilo, T, Cafferata, M A, Ardizzoni, A
Publicado em 2012

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

Por Ceresoli, G L, Zucali, P A, Mencoboni, M, Botta, M, Grossi, F, Cortinovis, D, Zilembo, N, Ripa, C, Tiseo, M, Favaretto, A G, Soto-Parra, H, De Vincenzo, F, Bruzzone, A, Lorenzi, E, Gianoncelli, L, Ercoli, B, Giordano, L, Santoro, A
Publicado em 2013